Production Capacity Expansion for Inorganic Salts


Nantong, China

Merck:/Freestyle/PS-Process-Solutions/SMP-Small-Molecule-Pharmaceuticals/salt-plant/nantog-top.png

In Q1 2020, we will go on-stream with our newly constructed excipients and APIs manufacturing plant, adding capacity to our global manufacturing network. This state-of-the art production plant enhances our supply reliability, serving you with multi-compendial Emprove® inorganic salts. Expanding our global manufacturing footprint into China will further strengthen our ability to serve specific regulatory requirements.

Merck:/Freestyle/PS-Process-Solutions/SMP-Small-Molecule-Pharmaceuticals/salt-plant/nantong-machine.jpg
Over the course of 2020, the first four parallel running manufacturing lines will be commissioned and qualified, with room for additional manufacturing lines in the same plant for future expansion.

This plant meets EU-, US-, CN GMP, ISO9001, and HACCP requirements and our well-established internal standards compiled in the Emprove®dossier. Featuring class D paper-free filling rooms the plant offers a wide range of packaging options from small sizes to big-bags to suit your needs.

The product list and further information for our new plant can be obtained from this landing page soon. Specific information will be shared through our change notification process according to the agreements in place.